Skip to main content
VITASORA HEALTH LIMITED logo

VITASORA HEALTH LIMITED — Investor Relations & Filings

Ticker · VHL ISIN · AU0000392748 ASX Manufacturing
Open in API
Filings indexed 1,338 across all filing types
Latest filing 2026-05-17 Regulatory Filings
Country AU Australia
Listing ASX VHL

About VITASORA HEALTH LIMITED

https://vitasorahealth.com.au/

VITASORA HEALTH LIMITED focuses on the development, sourcing, and distribution of health and wellness products. The company provides a range of nutritional supplements and dietary aids designed to enhance physical well-being and support long-term health goals. Its operations involve the selection of high-quality ingredients and the formulation of products that address specific health needs, including vitality and immune support. VITASORA HEALTH LIMITED serves a diverse market of health-conscious consumers by offering solutions that integrate modern nutritional science with accessible wellness formats. The company maintains a commitment to product integrity and consumer safety through rigorous quality assurance processes.

Recent filings

Filing Released Lang Actions
Vitasora Execute vCare Rollout - Revenue Scaling Accelerates 3 pages 152.1KB
Regulatory Filings Classification · 72% confidence The document is an ASX announcement providing an operational update on the vCare EMR rollout, patient enrollment metrics, expected cost savings, and progress toward cashflow breakeven. It does not present full financial statements or a formal quarterly/interim report (IR) but serves as a routine regulatory announcement to the market. It is not announcing the publication of another report (so not RPA), nor is it a standalone audit, management change, dividend notice, or any other specialized filing. Therefore, it falls under general regulatory filings.
2026-05-17 English
Appointment of Company Secretary 1
Board/Management Information Classification · 87% confidence The document is an ASX announcement notifying the resignation of current joint company secretaries and appointment of a new Company Secretary, which constitutes a change in senior management. This fits the Board/Management Information category.
2026-05-13 English
Quarterly Activities/Appendix 4C Cash Flow Report 15 pages 1.5MB
Interim / Quarterly Report Classification · 95% confidence The document is an ASX announcement titled 'APPENDIX 4C – QUARTERLY CASH FLOW AND ACTIVITIES REPORT' for the quarter ended 31 March 2026. It provides detailed financial and operational updates including revenue growth, patient program metrics, platform launch, and cash flow progress. The content includes substantive financial data and analysis for a quarterly period, not just a brief announcement or summary. The document is about quarterly financial and operational performance, consistent with an Interim / Quarterly Report. It is not a full annual report, nor a simple earnings release or regulatory filing. Therefore, the appropriate classification is Interim / Quarterly Report (IR). Q3 2026
2026-04-29 English
Investor Presentation 16 pages 1.7MB
Investor Presentation Classification · 95% confidence The document is a detailed presentation focused on the company's revenue growth strategies, operational efficiencies, and competitive advantages. It includes forward-looking statements, revenue projections, and explanations of business pillars driving growth. There are no financial statements, audit opinions, or regulatory certifications present. The content is structured as a presentation with slides and graphics (not included here) and is aimed at informing investors or stakeholders about the company's business model and growth prospects. This matches the characteristics of an Investor Presentation (IP) rather than an Annual Report, Earnings Release, or other regulatory filings. The length (12,240 characters) and detailed content support this classification with high confidence.
2026-03-18 English
Notification of Investor Briefing 2 pages 106.8KB
Investor Presentation Classification · 95% confidence The document is an ASX announcement dated 16 March 2026 from Vitasora Health Limited. It invites investors to an upcoming investor briefing scheduled for 19 March 2026, where the CEO will discuss revenue growth drivers and business initiatives. The document includes presentation details, contact information, company background, and forward-looking statements. It does not contain any financial statements, detailed financial analysis, or results. It is clearly an announcement of an investor presentation event rather than the presentation itself or a financial report. Therefore, the document fits best into the category of Investor Presentation (IP) as it relates to a detailed presentation for investors focusing on financials, strategy, and market position, even though the actual presentation materials are to be released later. The document is over 5,000 characters and provides substantive information about the event and company strategy, supporting the IP classification rather than a simple announcement (RPA).
2026-03-15 English
Application for quotation of securities - VHL 6 pages 18.3KB
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Appendix 2A - Application for quotation of securities' and is an official announcement from Vitasora Health Limited regarding the application for quotation of newly issued securities on the ASX. It references previous announcements (Appendix 3B) related to the securities issuance and provides detailed information about the number and type of securities to be quoted, issue price, and issued capital following quotation. This type of document is a formal application to list or quote securities on the stock exchange, which aligns with announcements related to share issues or capital changes. It is not a financial report, earnings release, or management report, but rather a regulatory announcement about capital structure changes. Therefore, the appropriate classification is 'Share Issue/Capital Change' (SHA). The document length and content confirm it is not merely a brief announcement but a full application form with substantive details.
2026-03-02 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.